Hence, our study aimed to confirm, by experimental approaches, some of the correlations suggested by bioinformatics analyses, and, thus, represented the first systematic evaluation of the expression levels of all twenty-five selenoproteins in androgen receptor-positive and -negative prostate cancer cells. This evidence concerns the gene SELENOS and prostate cancer.